These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 38372

  • 1. Change in the charactertistics of 3H-spiperone binding to rat striatal membranes after acute chlorpromazine administration: effects of buffer washing of membranes.
    Owen F, Cross AJ, Poulter M, Waddington JL.
    Life Sci; 1979 Jul 23; 25(4):385-90. PubMed ID: 38372
    [No Abstract] [Full Text] [Related]

  • 2. Two binding sites for 3H-spiroperidol on rat striatal membranes.
    Briley M, Langer SZ.
    Eur J Pharmacol; 1978 Aug 01; 50(3):283-4. PubMed ID: 28956
    [No Abstract] [Full Text] [Related]

  • 3. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
    Coupet J, Rauh CE.
    Eur J Pharmacol; 1979 Apr 15; 55(2):215-8. PubMed ID: 456420
    [Abstract] [Full Text] [Related]

  • 4. The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitro.
    Howard JL, Large BT, Wedley S, Pullar IA.
    Life Sci; 1978 Aug 14; 23(6):599-603. PubMed ID: 29198
    [No Abstract] [Full Text] [Related]

  • 5. Agonist interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
    Howlett DR, Morris H, Nahorski SR.
    Br J Pharmacol; 1979 May 14; 66(1):136P. PubMed ID: 454928
    [No Abstract] [Full Text] [Related]

  • 6. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
    Tachizawa H, Sudo K, Sano M.
    Eur J Pharmacol; 1979 Nov 16; 59(3-4):245-51. PubMed ID: 43256
    [Abstract] [Full Text] [Related]

  • 7. Lisuride inhibits 3H-spiroperidol binding to membranes isolated from striatum.
    Fujita N, Saito K, Yonehara N, Yoshida H.
    Neuropharmacology; 1978 Dec 16; 17(12):1089-91. PubMed ID: 745698
    [No Abstract] [Full Text] [Related]

  • 8. Ex vivo 3H-spiroperidol binding to rat striatum and the inhibitory effects of neuroleptics.
    Nakajima T, Egawa E, Kuruma I.
    Jpn J Pharmacol; 1981 Apr 16; 31(2):159-64. PubMed ID: 6118446
    [Abstract] [Full Text] [Related]

  • 9. Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration.
    Owen F, Cross AJ, Waddington JL, Poulter M, Gamble SJ, Crow TJ.
    Life Sci; 1980 Jan 07; 26(1):55-9. PubMed ID: 7189005
    [No Abstract] [Full Text] [Related]

  • 10. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
    Hall MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2973-7. PubMed ID: 6626267
    [Abstract] [Full Text] [Related]

  • 11. Analysis of dopamine interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
    Howlett DR, Nahorski SR.
    Br J Pharmacol; 1979 Jul 01; 66(3):468P-469P. PubMed ID: 526752
    [No Abstract] [Full Text] [Related]

  • 12. Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.
    Leysen JE, Gommeren W, Laduron PM.
    Biochem Pharmacol; 1978 Feb 01; 27(3):307-16. PubMed ID: 23126
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of the effects of substituted benzamides and standard neuroleptics on the binding of 3H-spiroperidol in the rat pituitary and striatum with in vivo effects on rat prolactin secretion.
    Meltzer HY, So R, Miller RJ, Fang VS.
    Life Sci; 1979 Aug 13; 25(7):573-83. PubMed ID: 41148
    [No Abstract] [Full Text] [Related]

  • 14. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S, Robson PA.
    Neuropharmacology; 1981 Dec 13; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract] [Full Text] [Related]

  • 15. The residual effect of chronic neuroleptic treatment on the neuroleptic binding assay in rats.
    Wan CW, Peck EJ, Ho BT, Schoolar JC.
    Life Sci; 1983 Mar 14; 32(11):1255-62. PubMed ID: 6834989
    [Abstract] [Full Text] [Related]

  • 16. Ovine prolactin administration modifies [3H]spiperone binding to striatal membranes of rabbits.
    Eva C, Blengio M, Ferretti C, Muccioli G, Portaleone P.
    Brain Res; 1982 Nov 18; 251(2):388-90. PubMed ID: 7139336
    [Abstract] [Full Text] [Related]

  • 17. The effect of cholecystokinin octapeptide on rat striatal 3H spiperone binding.
    O'Shaughnessy C, Poat JA, Turnbull MJ.
    Biochem Pharmacol; 1985 Aug 01; 34(15):2675-7. PubMed ID: 4015708
    [Abstract] [Full Text] [Related]

  • 18. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat.
    Lai HC, Carino MA, Horita A.
    Proc West Pharmacol Soc; 1981 Aug 01; 24():5-6. PubMed ID: 6114496
    [No Abstract] [Full Text] [Related]

  • 19. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Mar 02; 98(3-4):433-6. PubMed ID: 6144559
    [Abstract] [Full Text] [Related]

  • 20. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE, Gommeren W.
    J Neurochem; 1981 Jan 02; 36(1):201-19. PubMed ID: 7463046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.